🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cree Leukoencephalopathy (CLE) is a rare and fatal neurodegenerative disord...
Status
Active Not Recruiting
Location
McGill University Health Centre
Start Date
2024-11-14
Trial ID
NCT07272525
Treatments Being Tested
Fosigotifator is an investigational drug being researched for the treatment...
Status
Terminated
Location
UC Irvine Health ALS and Neuromuscular Center
Start Date
2021-09-22
Trial ID
NCT04948645
Treatments Being Tested
This study follows an open-label, single arm design with two periods with r...
Status
Completed
Location
AbbVie Clinical Pharmacology Research Unit (ACPRU)
Start Date
2023-03-24
Trial ID
NCT05763459
Treatments Being Tested
Major depressive disorder (MDD; depression) is a mood disorder that causes ...
Status
Terminated
Location
CenExel CNR /ID# 265866
Start Date
2024-10-23
Trial ID
NCT06618118
Treatments Being Tested
Fosigotifator is an investigational drug being researched for the treatment...
Status
Recruiting
Location
Massachusetts General Hospital /ID# 270960
Start Date
2023-03-13
Trial ID
NCT05757141
Treatments Being Tested
This is an expanded access program (EAP) for eligible participants. This pr...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06594016
Treatments Being Tested
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen cl...
Status
Completed
Location
Healey Center for ALS at Mass General
Start Date
2023-03-23
Trial ID
NCT05740813
Treatments Being Tested
The purpose of this study is to evaluate mass balance, pharmacokinetics and...
Status
Completed
Location
Fortrea Clinical Research Unit Inc.
Start Date
2024-05-21
Trial ID
NCT06425003
Treatments Being Tested
This study is a randomized, three period, six sequence, single dose crossov...
Status
Completed
Location
AbbVie Clinical Pharmacology Research Unit (ACPRU)
Start Date
2023-12-19
Trial ID
NCT06145607
Treatments Being Tested
This is a randomized, blinded, placebo and active-controlled, 4-period, cro...
Status
Completed
Location
AbbVie Clinical Pharmacology Research Unit (ACPRU)
Start Date
2024-03-14
Trial ID
NCT06310876
Treatments Being Tested